CG Oncology, Inc. Common stock (CGON) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CGON. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| RTW INVESTMENTS, LP | 6,984,808 | $473M | INCREASED |
| T. Rowe Price Investment Management, Inc. | 6,720,389 | $455M | INCREASED |
| Decheng Capital LLC | 6,371,669 | $431M | UNCHANGED |
| WELLINGTON MANAGEMENT GROUP LLP | 5,371,232 | $364M | DECREASED |
| BlackRock, Inc. | 5,064,180 | $343M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Leonard E Post (Director) | EXERCISE | 5,000 | $3K | 2026-06-22 |
| Leonard E Post (Director) | SELL | 5,000 | $325K | 2026-06-22 |
| James Mulay (Director) | EXERCISE | 1,310 | $16K | 2026-06-15 |
| James Mulay (Director) | EXERCISE | 654 | $2K | 2026-06-15 |
| James Mulay (Director) | SELL | 1,310 | $79K | 2026-06-15 |
Full institutional holdings, insider history, and congressional trades for CG Oncology, Inc. Common stock on SentiSense.